Ravandi, F., Alattar, M. L., Grunwald, M. R., Rudek, M. A., Rajkhowa, T., Richie, M. A., . . . Levis, M. (2013). Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation. American Society of Hematology.
Citação norma ChicagoRavandi, Farhad, et al. Phase 2 Study of Azacytidine Plus Sorafenib in Patients With Acute Myeloid Leukemia and FLT-3 Internal Tandem Duplication Mutation. American Society of Hematology, 2013.
Citação norma MLARavandi, Farhad, et al. Phase 2 Study of Azacytidine Plus Sorafenib in Patients With Acute Myeloid Leukemia and FLT-3 Internal Tandem Duplication Mutation. American Society of Hematology, 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.